Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Clinical impact of an angiotensin I-converting enzyme insertion/deletion and kinin B2 receptor +9/-9 polymorphisms in the prognosis of renal transplantation.

Amorim CE, Nogueira E, Almeida SS, Gomes PP, Bacurau RF, Ozaki KS, Cenedeze MA, Silva Filho AP, Câmara NO, Araujo RC.

Biol Chem. 2013 Mar;394(3):369-77. doi: 10.1515/hsz-2012-0314.

PMID:
23362199
2.

Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.

Hernández D, Lacalzada J, Rufino M, Torres A, Martín N, Barragán A, Barrios Y, Macía M, de Bonis E, Lorenzo V, Rodríguez A, González-Posada JM, Salido E.

Kidney Int. 1997 Apr;51(4):1205-11.

PMID:
9083287
4.

Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?

Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, De Zeeuw D, De Jong PE.

J Am Soc Nephrol. 1998 Nov;9(11):2075-81.

5.

Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival.

Beige J, Offermann G, Distler A, Sharma AM.

Nephrol Dial Transplant. 1998 Mar;13(3):735-8.

PMID:
9550656
6.

Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.

Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M.

Eur J Gastroenterol Hepatol. 2007 Nov;19(11):976-81.

PMID:
18049167
7.

Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.

Dayi SU, Tartan Z, Terzi S, Kasikcioglu H, Uyarel H, Orhan G, Alper AT, Ciloglu F, Cam N.

Heart Surg Forum. 2005;8(5):E373-7.

PMID:
16146835
8.

Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism.

Almeida SS, Barros CC, Moraes MR, Russo FJ, Haro AS, Rosa TS, Alves MF, Pesquero JB, Carmona AK, Bacurau RF, Araújo RC.

Neuropeptides. 2010 Apr;44(2):139-43. doi: 10.1016/j.npep.2009.12.003.

PMID:
20064660
9.

The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis.

Oruc N, Lamb J, Kutlu OC, Barmada MM, Money ME, Slivka A, Whitcomb DC.

JOP. 2004 Nov 10;5(6):457-63.

10.

Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.

Mukae S, Itoh S, Aoki S, Iwata T, Nishio K, Sato R, Katagiri T.

J Hum Hypertens. 2002 Dec;16(12):857-63.

11.

Angiotensin-converting enzyme polymorphism affects outcome of local Chinese with acute lung injury.

Lu XM, Chen GJ, Yang Y, Qiu HB.

Respir Med. 2011 Oct;105(10):1485-90. doi: 10.1016/j.rmed.2011.06.009.

12.

The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.

Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.

Singapore Med J. 2008 Nov;49(11):924-9.

13.
14.

Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy.

Fedor R, Asztalos L, Löcsey L, Szabó L, Mányiné IS, Fagyas M, Lizanecz E, Tóth A.

Transplant Proc. 2010 Jul-Aug;42(6):2304-8. doi: 10.1016/j.transproceed.2010.05.020.

PMID:
20692468
15.

ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS.

Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J, Siffert W.

Eur Respir J. 2007 Mar;29(3):482-8.

16.

Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer.

Usmani BA, Janeczko M, Shen R, Mazumdar M, Papandreou CN, Nanus DM.

Br J Cancer. 2000 Feb;82(3):550-2.

17.

Studies on angiotensin-converting enzyme insertion/deletion polymorphism and genotype distributions in Turkish preeclampsia patients.

Bereketoğlu C, Kasap M, Pazarbaşı A.

J Pregnancy. 2012;2012:108206. doi: 10.1155/2012/108206.

18.

Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease.

Taute BM, Handschug K, Taute R, Seifert H, Gläser C, Podhaisky H.

Vasa. 1998 Aug;27(3):149-53.

PMID:
9747149
19.

Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema.

Bas M, Hoffmann TK, Tiemann B, Dao VT, Bantis C, Balz V, Schultz-Coulon HJ, Stark T, Schuler P, Greve J, Ivens K, Bier H, Kojda G.

Br J Clin Pharmacol. 2010 Feb;69(2):179-86. doi: 10.1111/j.1365-2125.2009.03567.x.

20.

Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.

Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN.

Ren Fail. 2009;31(3):196-200. doi: 10.1080/08860220802669826.

PMID:
19288324

Supplemental Content

Support Center